| Literature DB >> 33820914 |
Ewelina Stelcer1,2,3, Katarzyna Kulcenty4,5, Marcin Rucinski6, Marta Kruszyna-Mochalska4,7, Agnieszka Skrobala4,7, Agnieszka Sobecka5,8, Karol Jopek6, Wiktoria Maria Suchorska4,5.
Abstract
Human induced pluripotent stem cells (hiPSCs) can be differentiated into chondrocyte-like cells. However, implantation of these cells is not without risk given that those transplanted cells may one day undergo ionizing radiation (IR) in patients who develop cancer. We aimed to evaluate the effect of IR on chondrocyte-like cells differentiated from hiPSCs by determining their gene and microRNA expression profile and proteomic analysis. Chondrocyte-like cells differentiated from hiPSCs were placed in a purpose-designed phantom to model laryngeal cancer and irradiated with 1, 2, or 3 Gy. High-throughput analyses were performed to determine the gene and microRNA expression profile based on microarrays. The composition of the medium was also analyzed. The following essential biological processes were activated in these hiPSC-derived chondrocytes after IR: "apoptotic process", "cellular response to DNA damage stimulus", and "regulation of programmed cell death". These findings show the microRNAs that are primarily responsible for controlling the genes of the biological processes described above. We also detected changes in the secretion level of specific cytokines. This study demonstrates that IR activates DNA damage response mechanisms in differentiated cells and that the level of activation is a function of the radiation dose.Entities:
Year: 2021 PMID: 33820914 PMCID: PMC8021574 DOI: 10.1038/s41598-021-86230-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Human-induced pluripotent stem cells (hiPSCs) underwent chondrogenic differentiation in a medium supplemented with TGF-β3 via EBs (A). The obtained chondrocyte-like cells revealed markers characteristic of chondrocytes, including aggrecan, type II collagen, cartilage-oligomeric matrix protein (COMP), and proteoglycans visualized by alcian blue staining (B). Those cells were treated with ionizing radiation at 1, 2 and 3 Gy (C).
Figure 2Dose distribution on axial, sagittal, and coronal views and a 3D view of VMAT plans created to irradiate the chondrocyte-like cells in the ART phantom. The air space simulating the esophagus was filled with wax surrounding an Eppendorf tube, as quasi-GTV (blue color), quasi-CTV (green color), and quasi PTV (orange color).
Figure 3Bubble plot of differentially-expressed genes from each group (1 Gy vs. controls; 2 Gy vs. controls; 3 Gy vs. controls) assigned to gene ontology (GO) terms where the red color represents GO terms whose genes are downregulated while green corresponds to GO terms of upregulated genes.
Figure 4The relationship between particular genes belonging to GO terms mapped as circos plots. LogFC values and gene symbols are shown on the left side of the graph. All of the genes were upregulated (A) or downregulated (B) in at least one group in the irradiated cells (1, 2 and 3 Gy) compared to controls.
Figure 5Expression of the most upregulated and downregulated mRNAs were: BTG2, ZMAT, FAS, DDB2, TP53INP1, DLGAP5, CCNE2, CENPE, KIF20B and microRNAs: hsa-miR-19a-3p, hsa-miR-362-3p, hsa-miR-34a-5p were validated by RT-qPCR.
Figure 6Heatmap with hierarchic clusterization of differentially expressed genes involved in the control of "cell cycle" and "cell division". The values represent the average fold changes after IR (1, 2, 3 Gy) versus controls. For TCGA data, the values show fold change from laryngeal tumor samples versus normal samples.
Figure 7Interaction between IR treatment-related genes and their miRNAs (analyses based on microarray study). Validated target-miRNA pairs are negatively correlated.
A total of 38 pro- and anti-inflammatory cytokine secretion to the medium collected from hiPSC-derived cells (basic FGF, CTACK, Eotaxin, G-CSF, GM-CSF, GRO-alpha, HGF, IFN-alpha 2, IFN-gamma, IL-1 alpha, IL-1 beta, IL-2, IL-2R alpha, IL-4, IL-6, IL-7, IL-8, IL-9, IL-12, IL-13, IL-17, IP-10, LIF, MCP-1, MCP-3, M-CSF, MIG, MIP-1 alpha, MIP-1 beta, PDGF-BB, NGF-beta, RANTES, SCF, SCGF-beta, SDF-1 alpha, TNF-alpha, TNF-beta, TRAIL) significantly changed after IR.
| Cytokine | Control | 1 Gy | 2 Gy | 2 Gy | ||||
|---|---|---|---|---|---|---|---|---|
| Mean (pg/ml) | SD | Mean (pg/ml) | SD | Mean (pg/ml) | SD | Mean (pg/ml) | SD | |
| Basic FGF | 19.648 | 5.273 | 21.490 | 2.179 | 18.333 | 3.029 | 24.775 | 1.437 |
| CTACK | 7.778 | 2.472 | 9.360 | 0.749 | 5.768 | 1.893 | 11.438 | 1.107 |
| Eotaxin | 0.973 | 0.256 | 1.180 | 0.270 | 0.340 | 0.307 | 1.448 | 0.249 |
| G-CSF | 314.197 | 28.588 | 254.550 | 48.708 | 201.782 | 10.046 | 359.657 | 27.892 |
| GM-CSF | 1.363 | 0.491 | 1.560 | 0.195 | 0.885 | 0.371 | 1.967 | 0.128 |
| GRO-alpha | 123.168 | 25.357 | 117.490 | 14.914 | 76.688 | 10.367 | 150.840 | 4.592 |
| HGF | 2312.825 | 177.547 | 1960.230 | 213.868 | 1207.147 | 411.302 | 2677.245 | 398.319 |
| IFN-alpha 2 | 6.705 | 1.626 | 6.975 | 0.594 | 4.520 | 1.230 | 8.743 | 0.925 |
| IFN-gamma | 32.530 | 8.820 | 27.623 | 3.593 | 19.493 | 5.463 | 39.433 | 4.167 |
| IL-1 alpha | 6.745 | 1.183 | 11.013 | 2.636 | 10.698 | 11.200 | 13.440 | 0.815 |
| IL-1 beta | 1.598 | 0.472 | 1.817 | 0.382 | 1.020 | 0.414 | 2.110 | 0.250 |
| IL-2 | 2.890 | 1.268 | 4.230 | 1.106 | 3.250 | 1.909 | 5.128 | 0.561 |
| IL-2R alpha | 6.285 | 2.236 | 7.258 | 0.954 | 4.650 | 1.802 | 9.245 | 0.972 |
| IL-3 | 0.223 | 0.050 | 0.290 | 0.082 | 0.293 | 0.112 | 0.283 | 0.059 |
| IL-4 | 7.515 | 2.248 | 7.300 | 0.254 | 5.090 | 0.393 | 9.755 | 0.168 |
| IL-6 | 103.108 | 41.508 | 93.668 | 14.068 | 64.303 | 19.406 | 132.747 | 12.367 |
| IL-7 | 3.800 | 1.462 | 7.825 | 1.694 | 9.005 | 0.926 | 7.338 | 0.879 |
| IL-8 | 677.113 | 181.044 | 510.815 | 78.278 | 327.653 | 32.520 | 797.178 | 35.676 |
| IL-9 | 9.873 | 1.523 | 12.588 | 1.227 | 5.738 | 2.262 | 15.790 | 0.703 |
| IL-12 | 85.910 | 29.446 | 76.348 | 12.313 | 50.360 | 15.115 | 107.678 | 15.479 |
| IL-13 | 0.643 | 0.299 | 1.008 | 0.106 | 1.075 | 0.0778 | 1.085 | 0.142 |
| IL-17 | 4.275 | 1.160 | 5.533 | 0.587 | 7.310 | 3.199 | 6.065 | 0.367 |
| IP-10 | 348.387 | 13.590 | 177.243 | 33.968 | 66.600 | 21.789 | 215.602 | 16.262 |
| LIF | 55.928 | 11.575 | 49.465 | 1.518 | 30.693 | 7.808 | 68.800 | 2.384 |
| MCP-1 | 1734.480 | 637.348 | 1682.113 | 57.251 | 1072.748 | 331.551 | 1937.448 | 63.911 |
| MCP-3 | 648.340 | 245.533 | 519.238 | 81.092 | 322.723 | 45.366 | 779.390 | 12.026 |
| M-CSF | 4.775 | 1.241 | 4.648 | 0.487 | 2.465 | 0.719 | 6.058 | 0.468 |
| MIF | 1268.858 | 146.577 | 1446.020 | 70.476 | 1201.818 | 297.113 | 1461.543 | 70.532 |
| MIG | 8.475 | 3.497 | 19.145 | 2.941 | 11.178 | 5.478 | 21.098 | 2.099 |
| MIP-1 alpha | 0.970 | 0.319 | 1.213 | 0.281 | 0.640 | 0.186 | 1.075 | 0,190 |
| MIP-1 beta | 10.583 | 5.196 | 19.758 | 10.370 | 6.823 | 1.852 | 11.310 | 4.546 |
| NGF beta | 17.983 | 5.930 | 21.703 | 2.334 | 12.658 | 1.154 | 29.325 | 0.924 |
| PDGF-BB | 22.680 | 7.070 | 24.740 | 3.225 | 14.783 | 3.941 | 31.728 | 4.881 |
| RANTES | 8.701 | 2.456 | 9.592 | 0.877 | 6.813 | 1.403 | 10.581 | 0.325 |
| SCF | 39.285 | 14.448 | 36.425 | 3.867 | 25.477 | 2.609 | 52.445 | 3.648 |
| SCGF-beta | 3448.343 | 153.597 | 2550.860 | 638.244 | 1258.005 | 382.718 | 3233.932 | 359.261 |
| SDF-1 alpha | 31.233 | 5.311 | 36.858 | 6.172 | 24.190 | 11.063 | 45.797 | 7.140 |
| TNF-alpha | 83.825 | 24.237 | 96.705 | 1.534 | 56.830 | 2.235 | 107.438 | 6.910 |
| TNF-beta | 9.330 | 2.040 | 9.302 | 2.051 | 4.048 | 0.972 | 11.572 | 0.577 |
| TRAIL | 462.770 | 174.123 | 440.743 | 81.543 | 249.300 | 29.693 | 641.723 | 21.068 |
The results are presented as mean values (pg/ml of secreted cytokine) with standard deviations.